275 related articles for article (PubMed ID: 16271109)
1. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products.
Plentz A; Hahn J; Knöll A; Holler E; Jilg W; Modrow S
Transfusion; 2005 Nov; 45(11):1811-5. PubMed ID: 16271109
[TBL] [Abstract][Full Text] [Related]
2. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
4. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
5. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients.
Jordan J; Tiangco B; Kiss J; Koch W
Vox Sang; 1998; 75(2):97-102. PubMed ID: 9784661
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 transmission by a high-purity factor VIII concentrate.
Wu CG; Mason B; Jong J; Erdman D; McKernan L; Oakley M; Soucie M; Evatt B; Yu MY
Transfusion; 2005 Jun; 45(6):1003-10. PubMed ID: 15935000
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
10. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
Baylis SA; Shah N; Minor PD
J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
[TBL] [Abstract][Full Text] [Related]
12. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.
Bonvicini F; Gallinella G; Cricca M; Ambretti S; Delbarba S; Musiani M; Zerbini M
J Med Virol; 2004 Oct; 74(2):272-6. PubMed ID: 15332276
[TBL] [Abstract][Full Text] [Related]
13. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.
Plentz A; Hahn J; Holler E; Jilg W; Modrow S
J Clin Virol; 2004 Sep; 31(1):16-9. PubMed ID: 15288608
[TBL] [Abstract][Full Text] [Related]
14. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
Seishima M; Mizutani Y; Shibuya Y; Arakawa C
Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
[TBL] [Abstract][Full Text] [Related]
15. Blood donor screening for parvovirus B19 in Germany and Austria.
Schmidt M; Themann A; Drexler C; Bayer M; Lanzer G; Menichetti E; Lechner S; Wessin D; Prokoph B; Allain JP; Seifried E; Hourfar MK
Transfusion; 2007 Oct; 47(10):1775-82. PubMed ID: 17714425
[TBL] [Abstract][Full Text] [Related]
16. Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection.
Arnold DM; Neame PB; Meyer RM; Soamboonsrup P; Luinstra KE; O'Hoski P; Garner J; Foley R
Transfusion; 2005 Mar; 45(3):394-8. PubMed ID: 15752157
[TBL] [Abstract][Full Text] [Related]
17. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19 infections in patients with chronic anemia.
Heegaard ED; Myhre J; Hornsleth A; Gundestrup M; Boye H
Haematologica; 1997; 82(4):402-5. PubMed ID: 9299850
[TBL] [Abstract][Full Text] [Related]
19. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]